Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 3;35(4):1155–1159. doi: 10.1016/j.pnpbp.2011.03.019

Table 1.

Demographics.

ECT (n=17) No ECT (n=23)
N (%)
N (%)
p
Gender (Male) 10 (59) 14 (61) 0.99
Education (College Graduate) 13 (77) 10 (50) 0.17
Abuse
 • Physical 6 (35) 4 (20) 0.46
 • Sexual 1 (6) 4 (21) 0.19
Substance Abuse
 • Self 7 (41) 6 (29) 0.50
 • ETOHAbuse
  • Self 7 (41) 5 (24) 0.31
  • Family (1st Degree) 5 (31) 7 (37) 0.99
  • Family (2nd Degree) 2 (13) 4 (21) 0.67
Family History
 • Depression 15 (88) 19 (91) 0.99
 • Suicide 6 (38) 8 (35) 0.88
MDD Subtype 0.41
 • Atypical 3 (19) 7 (37)
 • Melancholic 7 (44) 5 (26)
 • Neither 6 (38) 7 (37)
Illness History
 • Hospitalization 14 (82) 9 (39) 0.01
 • Suicide
  • Attempt 7 (41) 8 (35) 0.75
  • Ideation 13 (77) 12 (52) 0.19
  • Ideation at Admission 5 (29) 9 (39) 0.74
Mean (SD)
Mean (SD)
p
Age 46.5 (10.8) 46.6 (14.8) 0.99
BMI 28.9 (5.7) 30.9 (7.7) 0.38
Illness History
 • Age of Onset 21.5 (12.3) 21.5 (11.6) 0.99
 • Length of Current Episode (Months) 99.1 (108.8) 103.0 (163.4) 0.93
 • Length of Illness (Years) 25.4 (10.2) 25.3 (15.3) 0.99
 • Previous Episodes 32.3 (46.5) 17.3 (35.3) 0.28
Clinical Scales
 • MADRS 34.1 (5.6) 32.0 (4.3) 0.20
 • BPRS 35.8 (6.1) 36.0 (5.6) 0.93
 • CADSS 4.7 (10.1) 4.0 (5.6) 0.81
 • Suicide Ideation Scale 4.8 (6.7) 2.1 (4.7) 0.15